Broughton Chief Regulatory Officer, Dr. Nveed Chaudhary discusses business growth and Broughton’s plans to extend its service portfolio into adjacent markets.
Pharmaceuticals
The recently concluded Drug Delivery to the Lungs (DDL) conference in 2023 was more than just an annual gathering of professionals in the field—it was a vibrant reunion of old friends, a platform for groundbreaking science, and a showcase of the latest advancements in inhalation technology.
DDL always provides a friendly and welcoming environment for attendees to connect; this year was no exception. There is a feeling of community within the inhalation drug delivery field at this conference.
One consistent hallmark of DDL conferences is the exceptional quality of scientific presentations. The podium sessions and poster presentations once again demonstrated the cutting-edge research and advancements in drug delivery. A commendable nod goes to all the presenters who shared their insights and the DDL organizing committee for their tireless efforts in orchestrating a seamless event.
Amidst the discussions and exchanges, sustainability emerged as a prominent theme. Conversations with exhibitors highlighted a collective awareness of environmental impact, focusing on reducing the carbon footprint associated with inhalation technologies. The looming concern of plastic waste was also addressed, with initiatives aiming to extend the lifespan of inhalers—a small but significant step toward a more sustainable future.
The push for sustainability was mirrored in exploring new propellants with lower global warming potential. Attendees learned about the promising advancements in propellant technology that align with the industry's commitment to environmental responsibility. As the community collectively seeks greener alternatives, the strides made in this area are a testament to the dedication of those working towards a more eco-friendly drug delivery landscape. There seemed to be progress in inhalers using the new propellents compared to last year's event, demonstrating the priority of these types of products over the year.
Undoubtedly, one of the conference's hottest topics was the evolution of inhalation technology. Both formulation and novel devices took center stage as presenters delved into the latest breakthroughs. These discussions underscored the continuous pursuit of enhanced drug delivery efficacy and addressed the continuing issues associated with poor patient adherence to their therapy.
In conclusion, DDL 2023 was a resounding success, weaving together the fabric of community, science, and innovation. As the industry navigates today's challenges and anticipates tomorrow's opportunities, the collaborative spirit evident at the conference serves as a beacon guiding the way toward a sustainable and groundbreaking future in drug delivery.
Click here to learn more about our inhalation testing services.
